Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xyrem for Excessive Daytime Sleepiness and Nocturnal Sleep Disturbance in Mild to Moderate Parkinson's Disease
NCT00641186Phase 2Completed
- Sponsor
- Baylor College of Medicine
- Start
- Sep 2004
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sodium oxybate in Excessive Daytime Sleepiness (EDS), sleep disorder, sponsored by Baylor College of Medicine. Started Sep 2004; status: completed.
02
Drugs
sodium oxybate
03
Conditions
Excessive Daytime Sleepiness (EDS)sleep disorder
Beyond the preview
Go deeper on NCT00641186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00641186.